1 Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
2 Dipartimento di Medicina Sperimentale, Universita' dell'Aquila, Italy
3 Dipartimento di Medicina Sperimentale e Patologia, Universita' La Sapienza,
Roma, Italy
4 Dipartimento di Oncologia, Biologia e Genetica, Universita' di Genova,
Italy
5 Parco Scientifico Biomedico San Raffaele Roma, Italy
* Author for correspondence (e-mail: rodolfo.quarto{at}istge.it)
Accepted 1 April 2003
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Osteoprogenitors, Osteogenesis, Chondrogenesis, Bone-marrow stromal cells, Condensation
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Starting from previous in vivo and in vitro observations indicating that
chondrogenic differentiation does not preclude the further development of an
osteoblast-like phenotype in vitro (Bianco
et al., 1998; Galotto et al.,
1994
; Gentili et al.,
1993
; Jimenez et al.,
2001
), we asked whether this could be effectively investigated
taking advantage of the histological dimension and the three-dimensional
nature of the pellet culture system of marrow-derived skeletal progenitor
cells. We report here that, by appropriate manipulation of the system, not
only can true bone formation be obtained but also specific spatial and
temporal patterns of chondro- and osteogenesis are obtained in vitro that
culminate in the generation of an in vitro formed `organoid' that directly
mimics the formation of the bony collar around cartilage anlagen that occurs
during embryonic bone development.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell culture
BMSCs were obtained from iliac crest marrow aspirates of healthy donors
(age range 1-60 years). All the procedures were approved by an institutional
ethical review committee. After washing in PBS, mononucleated cells were
stained with 0.1% methyl violet in 0.1 M citric acid and counted. The cells
were then suspended in Coon's modified Ham's F12 medium supplemented with 10%
FCS and 1 ng ml-1 rhFGF-2 and plated at between
2x106 and 5x106 cells per 100 mm dish.
Medium was changed 3 days after plating and then twice a week thereafter.
Pellet culture
Cells from confluent cultures (20-25 days in culture, passage 0,
corresponding to 12-15 doublings) were released by 0.05% trypsin in 0.01%
EDTA, counted and used to generate pellet cultures conducive for
chondrogenesis in vitro, essentially as previously described
(Johnstone et al., 1998).
Briefly, 2.5x105 cells were centrifuged at 500
g in 15 ml polypropylene conical tubes and the resulting
pellets were cultured for 4-7 weeks. Control cultures were grown in a
serum-free chemically defined medium consisting of Coon's modified Ham's F12
medium supplemented with 10-6 M bovine insulin,
8x10-8 M human apo-transferrin, 8x10-8 M
bovine serum albumin, 4x10-6 M linoleic acid, 10-3
M sodium pyruvate (control medium). To induce chondrogenic differentiation,
the control medium was supplemented with 10 ng ml-1 rhTGFß1,
10-7 M dexamethasone and 2.5x10-4 M ascorbic
acid.
Cultures were incubated for 4 weeks at 37°C in an atmosphere containing 5% CO2; the medium was changed every 4-5 days and ascorbic acid added three times a week. To monitor chondrogenesis, cultures were harvested at 1-4 weeks and processed for histology (see below). At the end of the 4-week culture, some cultures were incubated for a further 2-3 weeks in a medium conducive for in vitro mineralization (control medium containing 7.0x10-3 M ß-glycerophosphate, 10-8 M dexamethasone and 2.5x10-4 M ascorbic acid), then fixed and processed for histology.
Histology
The cell aggregates were fixed with 4% formaldehyde in PBS for 10-15
minutes and routinely embedded in paraffin. Paraffin sections were stained
with haematoxylin-eosin, toluidine blue, alcian blue and alizarin red S, and
viewed in transmitted and polarized light microscopy.
Antibodies
Monoclonal antibodies against type I and type II collagen (SP1D8 and CIICI,
respectively) were obtained from the Developmental Studies Hybridoma Bank
(Department of Biological Sciences, University of Iowa). Supernatants from
hybridoma cultures were used undiluted (SP1D8) or concentrated ten times
(CIICI). A monoclonal antibody to human recombinant type X collagen (X53) was
kindly provided by K. von der Mark (Institute of Experimental Medicine,
Friedrich Alexander University of Erlangen, Germany); supernatant from
hybridoma culture was used undiluted. A rabbit antiserum raised against human
bone sialoprotein [BSP, LF6 - (Fisher et
al., 1995)] was kindly provided by L. W. Fisher (NIDCR, NIH,
Bethesda, MD) and was used at a dilution of 1:100 in PBS, 0.1% bovine serum
albumin (BSA). A rabbit antiserum raised against bovine osteocalcin
(cross-reactive with the human protein) was kindly provided by S. Robins
(Rowett Research Institute, Aberdeen, UK) and was used at a dilution of 1:500
in PBS, 10% goat serum.
Immunohistochemistry
Deparaffinized and rehydrated 5 µm sections were incubated with 3%
hydrogen peroxide in methanol for 30 minutes to inhibit endogenous peroxidase
activity. Some sections were subjected to digestion with 1 mg ml-1
hyaluronidase in PBS, pH 6.0 for 15 minutes at 37°C prior to use. Sections
were exposed to normal goat or pig serum (Dako, Glostrup, Denmark) diluted
1:10 in PBS, 0.1% BSA for 30 minutes before incubation with the primary
antibodies. Slides were then washed with PBS, 0.01% Triton X-100 (Sigma, St
Louis, MO) (four times for 5 minutes each), incubated with the secondary
biotinylated antibodies (1:200 or 1:500 in PBS, 0.1% BSA) for 30 minutes,
rinsed in PBS, 0.01% Triton X-100 (four times for 5 minutes each) and
incubated with peroxidase-conjugated ExtrAvidin (1:50 in PBS, 0.1% BSA) for 30
minutes. The peroxidase reaction was developed using either
3-amino-9-ethylcarbazole (AEC) or 3,3'-diaminobenzidine
tetrahydrochloride (DAB) as chromogens. All incubations were performed at room
temperature. After rinsing in distilled water, sections were dehydrated in
ascending ethanol solutions, cleared in xylene and mounted.
Transmission electron microscopy
In vitro generated tissues were decalcified in neutral buffered 10% EDTA or
left undecalcified. After washing in PBS, samples were postfixed for 1 hour at
4°C in 1% osmium tetroxide in cacodylate buffer, rinsed in water,
dehydrated through graded ethanol solutions, transferred in propylene oxide,
and embedded in epoxy resin (AralditeTM). Semithin sections were stained
with Azur II-Methylene Blue to select appropriate fields; ultrathin sections
were cut with diamond knives, placed on uncoated grids, contrasted with uranyl
acetate and lead cytrate and examined with a CM 10 Philips transmission
electron microscope.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
The in vitro generated cartilage `beads' grew in size progressively, reaching a plateau at day 14 (Fig. 2). Alcianophilia and metachromasia, two histochemical features of proteoglycan content in cartilage, were uniform throughout the cross-sectional areas of the cartilage `beads' up until day 14, when the beads reached their maximum size. After day 14, both alcianophilia and metachromasia continued to increase in intensity in the central region of the beads. After day 21, they began to disappear from a progressively wider peripheral zone. By day 28, a clear-cut zonal pattern had formed, with a non-basophilic collar of cellular tissue, up to 300 µm thick, encasing a central core of histologically and histochemically well-defined hyaline cartilage.
Immunoreactivity for type X collagen was not seen until day 21, at which point it became distinctive in individual cells and throughout the extracellular matrix in the central cartilaginous region of the tissue bead (data not shown), indicating progression to hypertrophy of chondrocytes differentiated in pellet culture.
BMSC pellets cultured in the absence of TGF-ß1 (control cultures) did not grow in size, nor did they generate any tissue structure reminiscent of cartilage (data not shown).
Osteogenesis in BMSC pellet cultures
BMSC pellets which had been cultured in the presence of TGF-ß1 for 28
days were transferred to mineralization medium and cultured for an additional
1-3 week period. Within one week of culture under conditions conducive to in
vitro mineralization, the peripheral collar of tissue had turned into a tissue
histologically reminiscent of bone (Fig.
3). The tissue was fully mineralized, whereas the central core of
hyaline cartilage had remained uncalcified, as demonstrated by alizarin red S
or von Kossa staining. Apparently, viable cells were encased in lacunar spaces
within the fully calcified bone-like matrix, reminiscent of osteocytes. The
bone-like matrix appeared as woven bone in polarized light microscopy. In
essence, a bony collar had formed around a cartilage core, closely mimicking
the events occurring during the early phases of endochondral ossification.
|
Electron microscopic analysis (Fig. 4) confirmed the occurrence of mineralization and demonstrated features typical of genuine cartilage and bone matrix. Central areas of the cartilage beads, exhibiting histological features of hyaline cartilage, contained widely spaced, thin, non-banded collagen fibrils and abundant proteoglycan granules. At the transition between the central areas and the outer collar of non-chondroid tissue, mineralization nodules appeared in the context of a typical cartilaginous matrix structure. More peripherally, thick and periodically banded collagen fibrils became predominant. In the outer portion of the peripheral collar, dense bundles of banded fibrils and extensive calcification were observed.
|
Spatial and temporal patterns of expression of bone matrix proteins
in BMSC pellet cultures
Because both bone- and cartilage-like matrix formed in our system, we
investigated the expression of characteristic bone matrix proteins during the
process leading to the in vitro generation of an osteochondral `organoid'. To
investigate the expression of type I collagen, we used a monoclonal antibody
recognizing the N-propeptide of type I procollagen, which is cleaved
extracellularly following secretion of procollagen molecules. Thus,
intracellular immunoreactivity could be taken as evidence of procollagen
synthesis and extracellular immunoreactivity as indicative of sites of initial
deposition associated with freshly secreted procollagen molecules. Expression
and initial deposition of type I collagen were spatially restricted to an
outer layer of tissue that progressively increased in thickness over time
(Fig. 5). Extracellular
immunoreactivity was restricted at all times to a thin rim of matrix marking
the outer boundary of the hyaline cartilage region. Intracellular
immunoreactivity for type I collagen N propeptide was detected in a
progressively thicker region of peripheral tissue. From day 14 onward,
extracellular immunoreactivity for type I collagen N-propeptide was lost in
the same region, probably as a result of matrix maturation, whereas
immunolabelling of procollagen producing cells remained distinctly
detectable.
|
Bone sialoprotein is specifically expressed during early stages of embryonic bone formation, and so we also analysed the production of BSP during in vitro perichondral osteogenesis in the pellet culture system (Fig. 6). BSP-producing cells were detected as early as day 7 and increased in number thereafter. At all time points, BSP-producing cells were spatially confined to the outer portion of the cartilage `beads'. At day 14, they formed a distinct peripheral region of BSP production. Between days 21 and 28, when physical growth of the beads had ceased, production of BSP shifted from the outermost portion of the beads to an adjacent, more central region. Overall, the spatial and temporal pattern of cellular immunolabelling for BSP and type I collagen N propeptide were closely similar to one another. Extracellular immunoreactivity for BSP only appeared in cultures exposed to mineralization-conducive conditions (day 28-42).
|
No immunoreactivity for osteocalcin was observed at any time during the chondrogenic period (days 1-28). Abundant extracellular immunoreactivity for osteocalcin was, by contrast, seen in cultures harvested during the mineralization period (days 35-49) within the peripheral rind of bone-like tissue (Fig. 6).
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Considering that the pellet-derived tissue beads stop growing in size
around day 14, the subsequent deposition of peripheral rind of bone-like
matrix must occur at the expenses of pre-existing cartilage. Thus, an internal
remodelling of cartilage to bone matrix occurs once the pellet-derived tissue
has reached its maximum size. Assuming a roughly spherical shape for the
tissue bead formed in vitro, approximately one-third of the volume of
unmineralized cartilage existing at day 14 is physically replaced by an equal
volume of bone-like tissue. Given the very different water contents of
unmineralized hyaline cartilage and mineralized bone, the actual matrix
remodelling taking place is even greater. The internal remodelling of
cartilage into bone in our system might reflect either a direct phenotypic
conversion of chondrogenic cells to an osteogenic phenotype or the local
selection over time of an osteogenic population replacing a chondrogenic one.
The former possibility would be consistent with prior in vitro and in vivo
evidence (Berry et al., 1992;
Gentili et al., 1993
;
Galotto et al., 1994
),
suggesting an eventual osteogenic fate of hypertrophic chondrocytes. The
non-clonal nature of our cell population prevents inferences about a direct
conversion of chondrocytes to osteoblasts. For the same reason, whether
chondrogenesis and osteogenesis in our cultures reflect the dual
differentiation potential, the existence of a single stromal progenitor cannot
be conclusively stated. The specific point of interest in our present results
rather rests upon the precise spatial and temporal pattern that chondro- and
osteogenesis obey in the pellet-culture system.
In vivo, embryonic bone formation occurs around cartilaginous anlagen
(rudiments) prior to the onset of endochondral ossification proper. This
peculiar spatial arrangement is closely mimicked in our culture system, in
which a rind of bone-like tissue forms around a core of hyaline and
mineralizing cartilage. Our system thus directly models the precise spatial
determinants of cell differentiation operating in development. Interestingly,
whereas cartilage only forms occasionally in open transplants of BMSCs
(Krebsbach et al., 1997;
Kuznetsov et al., 1997
;
Martin et al., 1997
),
cartilage and bone tissues that do form in closed transplantation systems
(diffusion chambers) (Ashton et al.,
1980
; Bab et al.,
1984
; Gundle et al.,
1995
) are organized in a spatial pattern similar to the one we
observe in vitro (cartilage in the interior, bone in the periphery). It is
plausible that a gradient of oxygen tension
(Ashton et al., 1980
;
Scott, 1992
) might be directly
involved in the generation of the spatial pattern observed in both
systems.
Although chondrogenesis and osteogenesis are spatially segregated in our
system, they partially overlap temporally. Initiation of osteogenesis occurs
simultaneously with chondrogenic differentiation but can only be completed
upon switching to mineralization-conducive conditions. During the
chondrogenesis phase, type I collagen and BSP are actively synthesized and the
proteoglycan content is reduced in the region that is to become mineralized,
bone-like tissue. By contrast, it is the exposure to a
mineralization-conducive environment that induces the production and
deposition of osteocalcin, and the deposition (but not the production) of BSP.
In vivo, production of BSP by differentiating osteoblasts in the presumptive
bony collar and in the adjacent outermost chondrocytes occurs simultaneously
and `primes' the subsequent deposition of the bony collar
(Bianco et al., 1991;
Bianco et al., 1993
;
Bianco et al., 1998
;
Riminucci et al., 1998
). Just
as our system models the formation of the bony collar in vitro, so our data on
the localization of BSP recapitulate the specific spatial and temporal pattern
of expression of BSP associated with the in vivo events.
The pellet culture of human BMSCs is generally taken as a good in vitro model of chondrogenesis. By showing the occurrence of bone deposition in the same system, our data highlight a hitherto unrecognized experimental benefit of the system. That is, the direct transition, in vitro, from a cell culture to an organ culture dimension. A number of specific, temporally defined events of bone morphogenesis, such as endochondral bone formation proper or ontogeny of the bone marrow, could in principle be modelled and dissected in terms of their molecular determinants by further exploring the experimental flexibility of the system.
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Ashton, B. A., Allen, T. D., Howlett, C. R., Eaglesom, C. C., Hattori, A. and Owen, M. (1980). Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin. Orthop. 151,294 -307.[Medline]
Bab, I., Howlett, C. R., Ashton, B. A. and Owen, M. E. (1984). Ultrastructure of bone and cartilage formed in vivo in diffusion chambers. Clin. Orthop. 187,243 -254.[Medline]
Beresford, J. N. (1989). Osteogenic stem cells and the stromal system of bone and marrow. Clin. Orthop. 240,270 -280.[Medline]
Beresford, J. N., Graves, S. E. and Smoothy, C. A. (1993). Formation of mineralized nodules by bone derived cells in vitro: a model of bone formation? Am. J. Med. Genet. 45,163 -178.[Medline]
Berry, L., Grant, M. E., McClure, J. and Rooney, P. (1992). Bone-marrow-derived chondrogenesis in vitro. J. Cell Sci. 101,333 -342.[Abstract]
Bianco, P. and Gehron Robey, P. (2000). Marrow
stromal stem cells. J. Clin. Invest.
105,1663
-1668.
Bianco, P. and Robey, P. (1999). Diseases of bone and the stromal cell lineage. J. Bone Miner. Res. 14,336 -341.[Medline]
Bianco, P., Fisher, L. W., Young, M. F., Termine, J. D. and Robey, P. G. (1991). Expression of bone sialoprotein (BSP) in developing human tissues. Calcif. Tissue Int. 49,421 -426.[Medline]
Bianco, P., Riminucci, M., Bonucci, E., Termine, J. D. and
Robey, P. G. (1993). Bone sialoprotein (BSP) secretion and
osteoblast differentiation: relationship to bromodeoxyuridine incorporation,
alkaline phosphatase, and matrix deposition. J. Histochem.
Cytochem. 41,183
-191.
Bianco, P., Cancedda, F. D., Riminucci, M. and Cancedda, R. (1998). Bone formation via cartilage models: the `borderline' chondrocyte. Matrix Biol. 17,185 -192.[CrossRef][Medline]
Deryugina, E. I., Ratnikov, B. I., Bourdon, M. A. and Muller-Sieburg, C. E. (1994). Clonal analysis of primary marrow stroma: functional homogeneity in support of lymphoid and myeloid cell lines and identification of positive and negative regulators. Exp. Hematol. 22,910 -918.[Medline]
Fisher, L. W., Stubbs, J. T., 3rd and Young, M. F. (1995). Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop. Scand. 266 (Suppl.),61 -65.
Friedenstein, A. J., Chailakhyan, R. K. and Gerasimov, U. V. (1987). Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 20,263 -272.[Medline]
Galotto, M., Campanile, G., Robino, G., Cancedda, F. D., Bianco, P. and Cancedda, R. (1994). Hypertrophic chondrocytes undergo further differentiation to osteoblast-like cells and participate in the initial bone formation in developing chick embryo. J. Bone Miner. Res. 9,1239 -1249.[Medline]
Gentili, C., Bianco, P., Neri, M., Malpeli, M., Campanile, G., Castagnola, P., Cancedda, R. and Cancedda, F. D. (1993). Cell proliferation, extracellular matrix mineralization, and ovotransferrin transient expression during in vitro differentiation of chick hypertrophic chondrocytes into osteoblast-like cells. J. Cell Biol. 122,703 -712.[Abstract]
Goshima, J., Goldberg, V. M. and Caplan, A. I. (1991). The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks. Clin. Orthop. 262,298 -311.[Medline]
Gundle, R., Joyner, C. J. and Triffitt, J. T. (1995). Human bone tissue formation in diffusion chamber culture in vivo by bone-derived cells and marrow stromal fibroblastic cells. Bone 16,597 -601.[CrossRef][Medline]
Haynesworth, S. E., Goshima, J., Goldberg, V. M. and Caplan, A. I. (1992). Characterization of cells with osteogenic potential from human marrow. Bone 13, 81-88.[Medline]
Jaiswal, N., Haynesworth, S. E., Caplan, A. I. and Bruder, S. P. (1997). Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 64,295 -312.[CrossRef][Medline]
Jimenez, M. J., Balbin, M., Alvarez, J., Komori, T., Bianco, P.,
Holmbeck, K., Birkedal-Hansen, H., Lopez, J. M. and Lopez-Otin, C.
(2001). A regulatory cascade involving retinoic acid, Cbfa1, and
matrix metalloproteinases is coupled to the development of a process of
perichondrial invasion and osteogenic differentiation during bone formation.
J. Cell Biol. 155,1333
-1344.
Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M. and Yoo, J. U. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238,265 -272.[CrossRef][Medline]
Krebsbach, P. H., Kuznetsov, S. A., Satomura, K., Emmons, R. V., Rowe, D. W. and Robey, P. G. (1997). Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63,1059 -1069.[Medline]
Kuznetsov, S. A., Krebsbach, P. H., Satomura, K., Kerr, J., Riminucci, M., Benayahu, D. and Robey, P. G. (1997). Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12,1335 -1347.[Medline]
Mackay, A. M., Beck, S. C., Murphy, J. M., Barry, F. P., Chichester, C. O. and Pittenger, M. F. (1998). Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 4,415 -428.[Medline]
Maniatopoulos, C., Sodek, J. and Melcher, A. H. (1988). Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res. 254,317 -330.[Medline]
Martin, I., Muraglia, A., Campanile, G., Cancedda, R. and
Quarto, R. (1997). Fibroblast growth factor-2 supports ex
vivo expansion and maintenance of osteogenic precursors from human bone
marrow. Endocrinology
138,4456
-4462.
Mastrogiacomo, M., Cancedda, R. and Quarto, R. (2001). Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells. Osteoarthritis Cartilage 9,S36 -S40.[CrossRef][Medline]
Muraglia, A., Cancedda, R. and Quarto, R.
(2000). Clonal mesenchymal progenitors from human bone marrow
differentiate in vitro according to a hierarchical model. J. Cell
Sci. 113,1161
-1166.
Quarto, R., Thomas, D. and Liang, C. T. (1995). Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif. Tissue Int. 56,123 -129.[Medline]
Riminucci, M., Bradbeer, J. N., Corsi, A., Gentili, C., Descalzi, F., Cancedda, R. and Bianco, P. (1998). Vis-a-vis cells and the priming of bone formation. J. Bone Miner. Res. 13,1852 -1861.[Medline]
Satomura, K., Krebsbach, P., Bianco, P. and Gehron Robey, P. (2000). Osteogenic imprinting upstream of marrow stromal cell differentiation. J. Cell. Biochem. 78,391 -403.[CrossRef][Medline]
Scott, J. E. (1992). Oxygen and the connective tissues. Trends Biochem. Sci. 17,340 -343.[CrossRef][Medline]
Sekiya, I., Colter, D. C. and Prockop, D. J. (2001). BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem. Biophys. Res. Commun. 284,411 -418.[CrossRef][Medline]
Sekiya, I., Vuoristo, J. T., Larson, B. L. and Prockop, D.
J. (2002). In vitro cartilage formation by human adult stem
cells from bone marrow stroma defines the sequence of cellular and molecular
events during chondrogenesis. Proc. Natl. Acad. Sci.
USA 99,4397
-4402.
Yoo, J. U., Barthel, T. S., Nishimura, K., Solchaga, L., Caplan,
A. I., Goldberg, V. M. and Johnstone, B. (1998). The
chondrogenic potential of human bone-marrow-derived mesenchymal progenitor
cells. J. Bone Joint Surg. Am.
80,1745
-1757.